Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 59.30 ($0.74) and traded as low as GBX 58 ($0.72). Tissue Regenix Group shares last traded at GBX 58 ($0.72), with a volume of 59,103 shares trading hands.
Tissue Regenix Group Stock Down 0.3 %
The company has a market cap of £41.31 million, a P/E ratio of -5,800.00 and a beta of 1.61. The company has a 50 day moving average of GBX 57.91 and a 200-day moving average of GBX 59.30. The company has a debt-to-equity ratio of 35.69, a current ratio of 3.74 and a quick ratio of 2.36.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- How to Profit From Growth Investing
- How to Invest in Small Cap Stocks
- The How and Why of Investing in Gold Stocks
- These Are the Dividend Stocks Insiders Bought in January
- Stock Analyst Ratings and Canadian Analyst Ratings
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
